Status:
TERMINATED
The Stroke Warning Information and Faster Treatment Study (SWIFT)
Lead Sponsor:
Columbia University
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purposes of this study are to determine the effectiveness of an interactive stroke educational program compared to standard educational materials and usual care, to increase stroke knowledge, and ...
Detailed Description
Rapid diagnosis and treatment of acute ischemic stroke is critical to reduce disability and death caused by stroke. While recombinant tissue plasminogen activator, or rt-PA, is the only approved treat...
Eligibility Criteria
Inclusion
- Diagnosed with cerebral infarction/TIA hospitalized at New York Presbyterian Hospital (Milstein Hospital and Allen Pavilion)
- 18 year-old and older at onset of the stroke
- Self-identified as of White, Black or Hispanic race-ethnicity
- Living in a household with a telephone
Exclusion
- Patients unable to give informed consent
- Discharged to nursing home or requiring 24 hour care.
- A Modified Rankin score \> 4 at baseline
- Severe aphasia or severe cognitive impairment limiting comprehension
- Pre-stroke dementia history
- Patients with end stage cancer, or other medical conditions resulting in mortality \</= 1 year
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
1635 Patients enrolled
Trial Details
Trial ID
NCT00415389
Start Date
February 1 2005
End Date
October 1 2012
Last Update
February 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurological Institute, 710 W 168th Street, 6th Floor, Room 640
New York, New York, United States, 10032